Dimenhydrinate Intoxication Management
Manage dimenhydrinate intoxication with supportive care focused on airway protection, benzodiazepines for seizures and agitation, and sodium bicarbonate for QRS widening, while avoiding physostigmine in the prehospital setting.
Initial Assessment and Triage
Immediate referral to emergency department is mandatory for:
- Any suicidal intent, intentional abuse, or malicious intent 1
- Moderate to severe symptoms: agitation, hallucinations, seizures, loss of consciousness, respiratory depression, abnormal muscle movements, staring spells, or inconsolable crying 1
- Ingestion ≥7.5 mg/kg or ≥300 mg (whichever is less) in patients ≥6 years old 1
- Ingestion ≥7.5 mg/kg in children <6 years old 1
Home observation is appropriate only when:
- No symptoms present AND >6 hours elapsed since ingestion 1
- Ingestion below toxic threshold with no or mild symptoms only 1
- Follow-up call at approximately 6 hours post-ingestion 1
Emergency Department Management
Airway and Breathing
Establish airway control immediately as dimenhydrinate causes anticholinergic syndrome with potential for rapid CNS depression or stimulation leading to loss of consciousness or seizures 2. Provide bag-mask ventilation followed by endotracheal intubation when protective airway reflexes are compromised.
Cardiac Monitoring
Critical pitfall: QTc prolongation can occur and precipitate torsade de pointes, even hours after presentation 3. Continuous cardiac monitoring is essential, particularly in patients with:
- Baseline QTc >480 msec 3
- History of cardiac abnormalities 3
- Co-ingestion of other QT-prolonging substances
Seizure Management
Benzodiazepines are first-line for seizures and agitation 1. Status epilepticus can develop rapidly—within one hour of massive ingestion—and can be fatal within two hours 4. Administer benzodiazepines aggressively when seizures or severe agitation present.
Cardiac Dysrhythmias
Administer sodium bicarbonate for QRS widening (>0.10 msec) 1. Dimenhydrinate's anticholinergic properties can cause ventricular dysrhythmias 4. Target serum pH 7.45-7.55 with 50-150 mEq sodium bicarbonate boluses 2.
For torsade de pointes:
- Immediate unsynchronized cardioversion if hemodynamically unstable 3
- Magnesium sulfate 2g IV push
- Correct electrolyte abnormalities
Physostigmine Considerations
Physostigmine should be reserved for in-hospital administration only 1, 5. While historically used for anticholinergic poisoning and can rapidly reverse symptoms 5, it carries significant risks:
- Can precipitate seizures, bradycardia, and asystole
- Contraindicated with QRS widening or cardiac conduction abnormalities
- Should never be administered prehospital or en route 1
Decontamination
Do NOT induce emesis 1. The rapid onset of CNS effects (loss of consciousness, seizures) makes emesis dangerous.
Do NOT administer activated charcoal en route to the emergency department due to aspiration risk from altered mental status 1.
Activated charcoal may be considered in-hospital if:
- Patient presents within 1 hour of ingestion
- Airway is protected (intubated or fully alert)
- No contraindications present
Supportive Care Specifics
Anticholinergic Syndrome Management
Monitor for and treat:
- Hyperthermia with cooling measures
- Urinary retention (may require catheterization) 6
- Severe agitation with benzodiazepines (NOT antipsychotics, which lower seizure threshold)
Gastrointestinal Complications
Critical complication: Ischemic bowel can develop from severe anticholinergic effects 4. Monitor for abdominal pain, distension, or signs of peritonitis in severe cases.
Disposition
ICU admission criteria:
- QTc prolongation with history of cardiac abnormalities 3
- Seizures or status epilepticus
- Hemodynamic instability or dysrhythmias
- Altered mental status requiring airway protection
- Massive ingestion (>5000 mg) 4
Observation period: Minimum 6 hours for asymptomatic patients with confirmed toxic ingestion 1. Extend to 24 hours if sustained-release formulation suspected or symptoms develop.
Special Populations
Chronic high-dose users may develop tolerance but remain at risk for cognitive impairment and withdrawal symptoms (severe nausea, vomiting, anxiety, muscle stiffness) requiring benztropine and lorazepam 7, 8.
Pediatric patients are particularly vulnerable to rapid symptom onset and require lower thresholds for ED referral (≥7.5 mg/kg) 1, 9.
Contact Poison Control
Call 1-800-222-1222 (US) for expert toxicology consultation in all cases 2. Regional poison centers provide specialized guidance for complex presentations and can assist with disposition decisions.